1Lascaux AS, Chosidow O. Current therapeutics in infectious dermatolo [J]. Presse Med, 2000, 29(19):1048-1052.
2Gross G, Pfister H. Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts [J]. Med Microbiol Immunol, 2003, 28(1):80-84.
3Boxman IL, Hogewoning A, Mulder LH, et al. Detection of human papillomavirus types 6 and 11 in pubic and perianal hair from patients with genital warts [J]. J Clin Microbiol, 1999, 37(7):2270-2273.
4von Krogh G, Dahlman-Ghozlan K, Syrianen S, et al. Potentialhuman papillomavirus reactivation following topical corticosteroid therapy of genital lichen sclerosus and erosive lichen planus [J].J Eur Acad Dermatol Venereol, 2002, 16(2):130-133.
5Goncalves MA, Burattini MN, Donadi EA, et al. Risk factors associated with genital warts in HIV-positive Brazilian women[J].Tumori, 2003, 89(1): 9-15.
6Opaneye AA. The cellular immune system in female patients with or without genital warts: a study of peripheral white blood cell components[J]. Int J STD AIDS, 1999, 10(12): 815-816.
7Frazer IH. The role of the immune system in anogenital human papillomavirus[J]. Australas J Dermatol, 1998, 39 Suppl 1: S5-S7.
8Avgerinou G, Georgala S, Theodoridis A, et al. Reduction of cell mediated immunity in patients with genital warts of long duration[J]. Genitourin Med, 1986, 62(6): 396-398.
9Yu HC, Cho BH, Chung M J, et al. A case of giant condylomata acuminata involving anus after renal transplantation[J]. Clin Nephrol, 2003, 59(3): 235-236.
10yon Krogh G, Dahlman-Ghozlan K, Syrjanen S. Potential human papillomavirus reactivation following topical corticosteroid therapy of genital lichen sclerosus and erosive lichen planus[J]. J Eur Acad Dermatol Venereol, 2002, 16(2): 130-133.
